Four key predictions for the future of clinical trials, examining how these changes will revolutionize the speed, efficiency, and reliability of bringing life-saving treatments to market. The post Future Trends for Clinical Trials in 2025 and Beyond appeared first on MedCity News.
Discover the cutting-edge AI software that empowers trauma and critical care teams with real-time, data-driven insights. The post TraumaCare.AI shaping the future of critical care with AI-powered innovation appeared first on MedCity News.
This week, the FDA granted clearance to Withings’ BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients. The post FDA Clears Withings’ New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients appeared first on MedCity News.
WellTheory has launched a new program that will address the link between autoimmune disease and hormone imbalances. The post WellTheory Announces Women’s Health Program to Address Hormonal Conditions appeared first on MedCity News.
The Teva Pharmaceuticals and Sanofi drug, duvakitug, showed statistically significant and clinically meaningful results in a Phase 2b study in ulcerative colitis and Crohn’s disease. The drug is part of an emerging class of therapies that target TL1A, a protein involved in signaling that drives inflammation. The post Teva and Sanofi Mid-Stage Data Reveal Shows…
Telehealth empowers men to take control of their health in a way that is easy, confidential, and fits into their busy lifestyles. The post The Future of Men’s Healthcare: A Path to Improved Access, Outcomes, and Cost Savings appeared first on MedCity News.
Solutions like AI-powered patient intake offer a tangible ROI by streamlining administrative tasks, reducing errors, and improving care quality. The post Let’s Rethink AI — Patient Intake Is the Perfect Place to Start appeared first on MedCity News.
Neurocrine Biosciences’ Crenessity is now FDA approved for treating classic congenital adrenal hyperplasia (CAH), a rare and potentially fatal endocrine disorder. The approval comes with a priority review voucher, which Neurocrine could sell for around $150 million. The post Neurocrine Lands FDA Nod for First New Treatment in Decades for Rare Endocrine Disorder appeared first…
Ayuda Medical offers a wearable device that can detect an overdose and call for help. The company has received support from the NIH and NIDA via the Small Business Innovation Research program. The post How One Company is Using an Armband to Combat the Overdose Crisis appeared first on MedCity News.
Zocdoc CEO Oliver Kharraz has some predictions about how healthcare will change in 2025 — including the rise of cash-pay services and the potential restructuring of Amazon’s healthcare assets. The post Zocdoc CEO Predicts 3 Ways the Healthcare Industry Will Change in 2025 appeared first on MedCity News.